AnTolRx, Inc.
PrivateLast Round
Series A
Sep 8, 2016
Total Funding Raised
$4M
Company Overview
AnTolRx, Inc. operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A round in September 2016.
AnTolRx, Inc. is a biotechnology company that develops novel nanoformulation-based therapies designed to treat autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AnTolRx, Inc. Comparables
Compare AnTolRx, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Integrated Nanotherapeutics | 90% | |
| Anokion | 86% | |
| Cour Pharma | 85% |
For institutional investors. Book with your work email.
AnTolRx, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
AnTolRx, Inc. Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 8, 2016
$4M round led by Pfizer and JDRF.
For institutional investors. Book with your work email.
AnTolRx, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AnTolRx, Inc.'s valuation, stock price, and market status.
Is AnTolRx, Inc. a public or private company?
AnTolRx, Inc. is a private company.
What is the current stock price of AnTolRx, Inc.?
AnTolRx, Inc. is a private company, so its shares have no public market price. Caplight tracks AnTolRx, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AnTolRx, Inc. worth (valuation)?
Valuation information for AnTolRx, Inc. is not publicly available.
Can I buy AnTolRx, Inc. stock?
AnTolRx, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AnTolRx, Inc.'s last funding round?
AnTolRx, Inc.'s most recent funding round was Series A on September 8, 2016.
Who are the main investors in AnTolRx, Inc.?
Key investors in AnTolRx, Inc. include Pfizer.
Will AnTolRx, Inc. IPO soon?
No public IPO plans have been announced for AnTolRx, Inc..
How can I track AnTolRx, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in AnTolRx, Inc.'s shares on secondary markets.